As of May 25
| -0.05 / -0.06%|
The 28 analysts offering 12-month price forecasts for Novartis have a median target of 80.40, with a high estimate of 99.31 and a low estimate of 65.44. The median estimate represents a -1.16% decrease from the last price of 81.35.
The current consensus among 32 polled investment analysts is to Hold stock in Novartis. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.